Kaijun Huang

698 total citations · 1 hit paper
19 papers, 478 citations indexed

About

Kaijun Huang is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Kaijun Huang has authored 19 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Kaijun Huang's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), MicroRNA in disease regulation (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Kaijun Huang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), MicroRNA in disease regulation (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Kaijun Huang collaborates with scholars based in China, United States and Taiwan. Kaijun Huang's co-authors include Zuyi Ma, Hongkai Zhuang, Baohua Hou, Chuanzhao Zhang, Zixuan Zhou, Xiaoshun He, Shiye Ruan, Fei Ji, Shanzhou� Huang and Yi Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Annals of Oncology.

In The Last Decade

Kaijun Huang

15 papers receiving 473 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation

2020 290 citations Chuanzhao Zhang, Shanzhou� Huang et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kaijun Huang China	7	330	231	102	70	64	19	478
Meng‐chao Wang China	11	303 0.9×	267 1.2×	149 1.5×	34 0.5×	70 1.1×	12	515
Yunshi Cai China	9	243 0.7×	210 0.9×	30 0.3×	60 0.9×	72 1.1×	21	382
Shiye Ruan China	8	380 1.2×	239 1.0×	19 0.2×	91 1.3×	91 1.4×	13	466
Zongqiang Hu China	11	377 1.1×	298 1.3×	53 0.5×	106 1.5×	62 1.0×	16	514
Ganxun Li China	12	232 0.7×	170 0.7×	34 0.3×	119 1.7×	108 1.7×	29	421
Qiangnu Zhang China	12	277 0.8×	217 0.9×	19 0.2×	65 0.9×	50 0.8×	24	372
Xianguo Zhou China	10	241 0.7×	159 0.7×	23 0.2×	93 1.3×	49 0.8×	22	345
Wenli Sai China	12	202 0.6×	151 0.7×	90 0.9×	48 0.7×	107 1.7×	32	366
Linghua Zhu China	9	130 0.4×	83 0.4×	43 0.4×	57 0.8×	34 0.5×	26	263

Countries citing papers authored by Kaijun Huang

Since Specialization

Citations

This map shows the geographic impact of Kaijun Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaijun Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaijun Huang more than expected).

Fields of papers citing papers by Kaijun Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaijun Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaijun Huang. The network helps show where Kaijun Huang may publish in the future.

Co-authorship network of co-authors of Kaijun Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Kaijun Huang. A scholar is included among the top collaborators of Kaijun Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaijun Huang. Kaijun Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Huang, Kaijun, et al.. (2025). Neutrophil-Mimicking Prussian blue nanozymes for synergistic targeted immuno-metabolic therapy of hepatic ischemia–reperfusion injury. Journal of Nanobiotechnology. 23(1). 736–736.

Huang, Kaijun, Xuanlin Zhang, Genquan Yin, et al.. (2025). Genetically engineered MSC-derived hybrid cellular vesicles for ROS-scavenging and mitochondrial homeostasis in hepatic ischemia-reperfusion injury. Materials Today Bio. 34. 102215–102215. 2 indexed citations

Huang, Kaijun, et al.. (2025). Lipid metabolism-related genes regulate the immune microenvironment during ex vivo lung perfusion for lung transplants. Journal of Thoracic Disease. 17(8). 6045–6065. 1 indexed citations

Lu, Weihua, Zhao Yang, Xiaohong Chen, et al.. (2024). Identification and validation of biomarkers related to mitochondria during ex vivo lung perfusion for lung transplants based on machine learning algorithm. Gene. 936. 149097–149097. 1 indexed citations

Huang, Kaijun, et al.. (2024). First metagenomic sequencing for the analysis of microbial community populations of adults and pupae of Melophagus ovinus in Xinjiang, China. Frontiers in Veterinary Science. 11. 1462772–1462772.

Huang, Kaijun, et al.. (2024). Molecular Investigation of Bartonella melophagi and the First Report of Trypanosoma melophagium in Melophagus ovinus from Southern Xinjiang, China. Pakistan Veterinary Journal. 1 indexed citations

Zhong, Wenhui, et al.. (2021). Development and Validation of a Nomogram Based on Noninvasive Liver Reserve and Fibrosis (PALBI and FIB-4) Model to Predict Posthepatectomy Liver Failure Grade B-C in Patients with Hepatocellular Carcinoma. Journal of Oncology. 2021. 1–10. 11 indexed citations

Zhang, Feng, et al.. (2021). Integrative Analysis of Metallothioneins Identifies MT1H as Candidate Prognostic Biomarker in Hepatocellular Carcinoma. Frontiers in Molecular Biosciences. 8. 672416–672416. 4 indexed citations

Zhang, Feng, et al.. (2021). TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer. Frontiers in Cell and Developmental Biology. 9. 665265–665265. 11 indexed citations

10.

Zhang, Chuanzhao, Shanzhou� Huang, Hongkai Zhuang, et al.. (2020). YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene. 39(23). 4507–4518. 290 indexed citations breakdown →

11.

Zhuang, Hongkai, Zuyi Ma, Kaijun Huang, et al.. (2020). Establishment of a 7-miRNA–Based Risk Score System for Predicting Prognosis of Pancreatic Cancer. Pancreas. 49(5). 655–662. 4 indexed citations

12.

Huang, Kaijun, Wenxuan Xie, Shutong Wang, et al.. (2020). High SPINK1 Expression Predicts Poor Prognosis and Promotes Cell Proliferation and Metastasis of Hepatocellular Carcinoma. Journal of Investigative Surgery. 34(9). 1011–1020. 21 indexed citations

13.

Zhang, Pu & Kaijun Huang. (2018). Changes of fibrinogen and D-dimer in patients with severe burns and their relationship with prognosis. Zhongguo jiceng yiyao. 25(8). 988–990.

14.

Huang, Kaijun & Jennifer Wu. (2017). Targeting the PD-1 Pathway in MSI-Stable Metastatic Colorectal Cancer. 6(1). 1 indexed citations

15.

Huang, Kaijun, et al.. (2016). Global profiling of the signaling network of papillary thyroid carcinoma. Life Sciences. 147. 9–14. 6 indexed citations

16.

Huang, Kaijun, et al.. (2016). Combined Chronic Lymphocytic Leukemia and Pancreatic Neuroendocrine Carcinoma: A Collision Tumor Variation. SHILAP Revista de lepidopterología. 2(3). 90–90.

17.

Wang, Shu, Kaijun Huang, Bowen Huang, et al.. (2015). MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer. Cancer Biomarkers. 15(5). 535–542. 32 indexed citations

18.

Wu, Shixiu, X. Zhang, Bing Xia, et al.. (2014). Interim Results of a Randomized Controlled Phase III Trial of Elective Nodal Irradiation Plus Erlotinib Combined with Chemotherapy for Esophageal Squamous Cell Carcinoma (Nct00686114). Annals of Oncology. 25. iv211–iv211. 1 indexed citations

19.

Huang, Kaijun, Qian Zhou, Rong Wang, Donghui Cheng, & Yi Ma. (2013). Doxorubicin‐eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 29(5). 920–925. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact